Despite its serious implications ... which is more common in other urea cycle disorders[2]. Current management strategies primarily involve dietary restrictions to lower arginine intake, but ...

The Urea Cycle Disorders market size is anticipated to ... iECURE received FDA clearance for its Investigational New Drug (IND) application for ECUR-506 for OTCD. . In December 2023, the European ...

It is driven by the increasing prevalence of UCDs. The global urea cycle disorder (UCD) treatment market is projected to grow by $215.4m from 2024 to 2028, at a CAGR of 3.2%, according to Technavio.